52w high/low | ₹1.33 / ₹0.37 |
P/E ratio | -8.79 |
Dividend | 0 |
ROE | -59 |
ROCE | -10.31 |
Face value | 10 |
Book value | ₹0.8Cr |
Market capital | ₹7.89Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Advik Laboratories Limited is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. Advik Laboratories Limited has a technical collaboration with PFC Pharma Focus Ltd. The company is based in New Delhi, India. It also markets its products in the Middle East, South America, and Africa. Advik Laboratories Limited was promoted in the 1994 by Jain along with a group of dedicated professionals. The company commenced commercial production in 1997.